Here you go P2S:
$VDRM
•Generating revenues
•Small share structure and float
•No toxics, debt, nor dilution
•12.5 Million dollar licensing contract being finalized (late June) 10 years @ 1.25 per yr
•Pink current
•FDA registered product
•Completely funded
•Large hospital chain contract in pipeline (announced late May)
•Product at 100 reviews on Amazon
*BULLISH pennant chart
About the Product:
<Topical Ointment>
Patented Technology (transdermal Infusion vs. intravenous)
Vitastem’s Patented Transdermal Technology: 1. Allows the transfer of chemicals through the outer layer of skin with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the skin. This novel approach uses an antibiotic formulation designed to enhance physical transport and physical cell penetration that speeds the active ingredient deep into the cell structure of a wound where the chemical mechanism of action can be more effective. 2. Kills with both a physical and chemical mechanism, giving it a unique ability to overcome drug resistant bacteria.
Hospital Grade Topical Antibiotic for Treating Infections, Wounds, Diabetic Foot Ulcers, Bed & Pressure Sores, Burns, Skin Rash, Acne and Wounds associated with Eczema and Psoriasis.
Have a good week
Yak